Evidence map›Paper›PMID 40548163›Full record

ArticleAdvances in radiation oncology2025

Monitoring of Early Skin Reactions by Optical Coherence Tomography and Dermatoscopy in Patients Receiving Radiation Therapy for Head and Neck Cancer.

Bettina Heise, Peter Schlagnitweit, Robert Pollak, Karoline Felbermayer, Elisabeth Silberberger, Lukas Kocik, Leonhard Trinkl, David Weinzinger, Philipp Anderlik, Andreas Springer and 4 more

Registry-linked trialAbstract read
In one paragraph

Article in Advances in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04610645 (Live Laser Microscopic Evaluation), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04610645 completednot on this map

Live Laser Microscopic Evaluation (OCT) of Radiation Induced Preclinical Alterations of the Skin in Head and Neck Cancer Patients

TypeobservationalSponsorKrankenhaus Barmherzige Schwestern LinzRan2020 to 2025Enrolled30ConditionsHead and Neck Cancer, RadiotherapyArmsOCT, Dermatoscope
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bettina HeiseInstitute for Mathematical Methods in Medicine and Data Based Modelling, Johannes Kepler University (JKU), Linz, Austria.
Peter SchlagnitweitInstitute for Mathematical Methods in Medicine and Data Based Modelling, Johannes Kepler University (JKU), Linz, Austria.
Robert PollakInstitute for Mathematical Methods in Medicine and Data Based Modelling, Johannes Kepler University (JKU), Linz, Austria.
Karoline FelbermayerResearch Center for Non-Destructive Testing (RECENDT)-GmbH, Linz, Austria.
Elisabeth SilberbergerDepartment of Radiation Oncology, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.
Lukas KocikDepartment of Radiation Oncology, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.
Leonhard TrinklDepartment of Radiation Oncology, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.
David WeinzingerDepartment of Radiation Oncology, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.
Philipp AnderlikDepartment of Radiation Oncology, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.
Andreas SpringerDepartment of Radiation Oncology, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.
Marija Geroldinger-SimicDepartment of Dermatology, Ordensklinikum Linz (OKL), Elisabethinen, Linz, Austria.
Georg GruberDepartment of Radiation Oncology, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.
Maximilan HartlDepartment of ENT, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.
Hans GeinitzDepartment of Radiation Oncology, Ordensklinikum Linz (OKL), Barmherzige Schwestern, Linz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Patients with head and neck cancer undergoing radiation therapy (RT) may experience pronounced acute skin reactions. We tested whether optical coherence tomography (OCT) and dermatoscopy could detect and monitor early subclinical RT-induced skin changes and might be used as a noninvasive prediction tool for higher-grade acute toxicity. Methods and Materials: Handheld OCT and dermatoscopy were used to monitor skin conditions during RT in head and neck cancer patients. Images were reviewed for typical and suspicious features facilitated by electronic image analyses. Radiation toxicity was graded weekly by a radiation oncologist. Machine learning was used to analyze the recorded data and to extract features, patterns/anomalies, and risk prediction values for high-grade radiation toxicity. Results: The most common skin features during RT observed by OCT were expressions of hyperkeratosis, blister formation, and in selected cases, formation of extensive microvascular structures or stratification disorder. Dermatoscopy revealed an almost linear increase in skin redness and saturation over the course of RT. By integrating all imaging and clinical data from RT weeks 1 to 3, it was possible to predict an increased risk of severe radiation toxicity (National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) grade 3 or higher) in the second half of RT. A prediction accuracy of 72%, 75%, and 77% was achieved with OCT and clinical assessment, dermatoscopy and clinical assessment, and all 3 modes combined, respectively. Conclusions: OCT and dermatoscopy can detect early radiation-induced skin changes at a subclinical level. Dermatoscopy is more accessible, whereas OCT requires training and further electronic processing to interpret images. Dermatoscopy, but not OCT, can quantify skin color changes, whereas OCT is able to deliver unique information on epidermal suspicious microstructural changes.

Identifiers

PMID40548163
PMCPMC12182290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.